TY - JOUR T1 - Development of a Deep Learning Model for Early Alzheimer’s Disease Detection from Structural MRIs and External Validation on an Independent Cohort JF - medRxiv DO - 10.1101/2021.05.28.21257318 SP - 2021.05.28.21257318 AU - Sheng Liu AU - Arjun V. Masurkar AU - Henry Rusinek AU - Jingyun Chen AU - Ben Zhang AU - Weicheng Zhu AU - Carlos Fernandez-Granda AU - Narges Razavian AU - for the Alzheimer’s Disease Neuroimaging Initiative Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/01/2021.05.28.21257318.abstract N2 - Early diagnosis of Alzheimer’s disease plays a pivotal role in patient care and clinical trials. In this study, we have developed a new approach based on 3D deep convolutional neural networks to accurately differentiate mild Alzheimer’s disease dementia from mild cognitive impairment and cognitively normal individuals using structural MRIs. For comparison, we have built a reference model based on the volumes and thickness of previously reported brain regions that are known to be implicated in disease progression. We validate both models on an internal held-out cohort from The Alzheimer’s Disease Neuroimaging Initiative (ADNI) and on an external independent cohort from The National Alzheimer’s Coordinating Center (NACC). The deep-learning model is more accurate and significantly faster than the volume/thickness model. The model can also be used to forecast progression: subjects with mild cognitive impairment misclassified as having mild Alzheimer’s disease dementia by the model were faster to progress to dementia over time. An analysis of the features learned by the proposed model shows that it relies on a wide range of regions associated with Alzheimer’s disease. These findings suggest that deep neural networks can automatically learn to identify imaging biomarkers that are predictive of Alzheimer’s disease, and leverage them to achieve accurate early detection of the disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSL was partially supported by NSF DMS-2009752, NSF NRT-HDR-1922658, and Leon Lowenstein Foundation. NR was partially supported by Leon Lowenstein Foundation and NIH/NIA P30AG066512. AVM was partially supported by NIH/NIA P30AG008051 and P30AG066512. HR was partially supported by NIH/NIA P30AG066512 and NIA/NIBIB U24EB028980. JC was partially supported by NIH/NIA P30AG066512 and NIH-NINDS 1RF1NS110041-01.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The datasets used in this analysis are both de-identified and publicly available and therefore we did not need to get IRB approval for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesBoth cohorts used in our study are publicly available at no cost upon completion of the respective data-use agreements. We used all the T1 MRI scan and clinical data from ADNI (June 15th 2019 freeze), and NACC (Jan 5th 2019 freeze). The IDs of patients and scans used in our study and training, validation, test indicators are available in our github repository. Results of our freesurfer segmentation (results of over 60,000 compute time on our HPC) for all of NACC and ADNI scans are also publicly available at no cost through NACC and ADNI websites, to anyone who has signed ADNI and NACC data-use agreements. Our trained model, training and validation scripts, and model predictions for each scan ID and patient ID, as well as freesurfer segmentation volume and thickness features are also available as open-source on github. ER -